Form 4: Bausch Health Director John Paulson Significantly Increases Stake with Multi-Million Dollar Stock Purchases

Bausch Health Companies Inc. Director and 10% owner John Paulson, through managed funds, has significantly increased his indirect beneficial ownership in the company by acquiring over 2.7 million shares across three transactions in June 2025.

Summary

• John Paulson, a Director and 10% owner of Bausch Health Companies Inc. (BHC), indirectly acquired a total of 2,788,608 shares of common stock through managed funds across three separate transactions.
• On June 10, 2025, 754,134 shares were purchased at an average price of $5.05 per share.
• On June 11, 2025, an additional 1,029,098 shares were acquired at an average price of $5.24 per share.
• On June 12, 2025, a further 1,005,376 shares were bought at an average price of $5.47 per share.
• Following these transactions, John Paulson's indirect beneficial ownership, through managed funds, increased to 29,227,643 shares of Bausch Health common stock.

Sentiment

Score: 9

Explanation: The significant and consecutive purchases of common stock by a major insider (Director and 10% owner) like John Paulson, especially at increasing prices, convey a very strong positive sentiment and confidence in the company's future prospects and valuation.

Positives

• Significant insider buying by a Director and 10% owner, John Paulson, indicates strong confidence in the company's future prospects.
• The purchases were made at increasing price points ($5.05, $5.24, $5.47), suggesting a belief in continued upward momentum or undervaluation.
• The substantial increase in indirect beneficial ownership to over 29 million shares reinforces a long-term commitment to the company.

Risks

• The reporting person, John Paulson, disclaims beneficial ownership of the securities except to the extent of his pecuniary interest, as the shares are directly owned by investment funds managed by Paulson Capital Inc. This is standard for such filings but clarifies the nature of the ownership.

Future Outlook

This Form 4 filing does not provide explicit forward-looking statements or guidance from the company. However, significant insider purchases are often interpreted as a positive signal regarding management's internal outlook on future performance.

Management Comments

• John Paulson, the controlling person of Paulson Capital Inc. ('Paulson'), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the 'Funds'). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds.
• Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the 'Act'), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein.
• This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.

Industry Context

Insider buying, especially by a significant shareholder and director like John Paulson, can be a strong indicator of perceived value within the pharmaceutical and healthcare industry. In a sector often subject to regulatory changes, R&D risks, and patent cliffs, such a vote of confidence from a major investor can differentiate a company from its peers.

Comparison to Industry Standards

• While direct comparisons to specific companies or projects are not provided in a Form 4, the scale of John Paulson's investment (over 29 million shares) is substantial for an individual insider, even if held indirectly through funds. This level of commitment is generally viewed more favorably than smaller, routine insider purchases or sales, suggesting a high conviction in Bausch Health's valuation or strategic direction compared to other investment opportunities in the healthcare sector.

Related Party Transactions

• The transactions involve shares held indirectly by investment funds managed by Paulson Capital Inc., where John Paulson is the controlling person. This represents a transaction between a director/10% owner and the company, albeit through managed entities.

Stakeholder Impact

• Shareholders: Existing shareholders may view this as a strong positive signal, potentially increasing confidence and attracting new investors, which could positively impact the stock price.
• Employees: While not directly impacted, a stronger stock performance due to investor confidence could indirectly benefit employees through stock-based compensation or overall company stability.

Key Dates

Recommendation

Keywords

Bausch Health Companies Inc., BHC, John Paulson, insider trading, Form 4, stock purchase, beneficial ownership, director, 10% owner, equity acquisition